Fluidra (FDR) Q3 2024 earnings summary

Executive summary

• Q3 2024 saw strong sales growth across all regions, led by North America and a return to growth in Europe after nine negative quarters.

• Gross margin improved significantly, supported by the ongoing Simplification Program.

• Robust cash generation enabled a €161 million reduction in net debt year-over-year, with improved working capital.

• Two bolt-on acquisitions in Portugal and Australia reinforced market leadership.

• Awarded Vendor of the Year by U.S. distributors for the fourth consecutive year, highlighting customer-centricity.

Financial highlights

• Sales for the first nine months rose 0.8% year-over-year to €1,637 million; Q3 standalone sales grew 7.3%.

• EBITDA increased 5.6% year-over-year to €386 million, with a margin of 23.6%, up 110 basis points.

• Net profit reached €123 million, up from €108 million in 2023; cash net profit was €194 million, up 8%.

• Free cash flow for the period was €113 million, higher than last year.

• Net debt declined to €1,069 million, with a leverage ratio of 2.3x EBITDA, down from 2.9x last year.

Outlook and guidance

• Full-year 2024 guidance updated: sales expected between €2,060–2,100 million, EBITDA €460–480 million, and cash EPS €1.14–1.20.

• Early buy campaign is ahead of last year, providing strong visibility and confidence for Q1 2025.

• Price increases implemented in October: low- to mid-single digits in the U.S., 1–2% in Europe, expected to add 1–2% to 2025 topline.

• Simplification Program on track to deliver €100 million in savings by end of 2025.

• Management remains confident in profitable growth and improving returns on capital.